Revolution Medicines RVMDW
NASDAQ RVMDW
$9.68 +0.15 (+1.51%)
As of: Oct 29, 2026 · 1:02 PM EDT

Revolution Medicines (RVMDW) EBITDA (2019 - 2026)

Updated

Revolution Medicines (RVMDW) posted EBITDA of -$502.68 million for Q2 2026, compared with -$262.12 million a year earlier.

Analysis

Revolution Medicines (RVMDW) EBITDA (2019 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, EBITDA at Revolution Medicines was -$1.62 billion; for FY2025, it was -$1.17 billion.

  • In prior years, Revolution Medicines' EBITDA was -$681.87 million in FY2024, -$481.04 million in FY2023, -$253.21 million in FY2022 and -$183.81 million in FY2021.
  • The Q2 2026 figure stands as the lowest quarterly EBITDA in data going back to Q1 2019.
  • According to Business Quant data, EBITDA for the three prior quarters was -$442.88 million (Q1 2026), -$359.26 million (Q4 2025) and -$313.44 million (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -502.68 Mn
Mar 31, 2026 -442.88 Mn
Dec 31, 2025 -359.26 Mn
Sep 30, 2025 -313.44 Mn
Jun 30, 2025 -262.12 Mn
Mar 31, 2025 -238.77 Mn
Dec 31, 2024 -214.28 Mn
Sep 30, 2024 -173.77 Mn
Jun 30, 2024 -154.70 Mn
Mar 31, 2024 -139.02 Mn
Dec 31, 2023 -178.38 Mn
Sep 30, 2023 -121.65 Mn
Jun 30, 2023 -107.27 Mn
Mar 31, 2023 -73.65 Mn
Dec 31, 2022 -60.26 Mn
Sep 30, 2022 -75.24 Mn
Jun 30, 2022 -60.86 Mn
Mar 31, 2022 -56.75 Mn
Dec 31, 2021 -51.78 Mn
Sep 30, 2021 -52.07 Mn
API Access

Revolution Medicines EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda&ticker=RVMDW&period=max&api_key=YOUR_API_KEY